HT update: spotlight on estradiol/norethindrone acetate combination therapy

Colleen L Casey, Christine A MurrayUniversity of Vermont, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Burlington, VT, USAAbstract: The goal of postmenopausal hormone therapy is to alleviate the symptoms that are associated with the loss of estroge...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Colleen L Casey, Christine A Murray
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/f9a3f396214e4f22b59bcdaf6fcde6f3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f9a3f396214e4f22b59bcdaf6fcde6f3
record_format	dspace
spelling	oai:doaj.org-article:f9a3f396214e4f22b59bcdaf6fcde6f32021-12-02T03:03:38ZHT update: spotlight on estradiol/norethindrone acetate combination therapy1178-1998https://doaj.org/article/f9a3f396214e4f22b59bcdaf6fcde6f32008-03-01T00:00:00Zhttps://www.dovepress.com/ht-update-spotlight-on-estradiolnorethindrone-acetate-combination-ther-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Colleen L Casey, Christine A MurrayUniversity of Vermont, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Burlington, VT, USAAbstract: The goal of postmenopausal hormone therapy is to alleviate the symptoms that are associated with the loss of estrogen. Many formulations of estrogen and progestin are available, depending on the needs and circumstances of each individual woman. For postmenopausal women, the choice of whether or not to begin therapy requires knowledge of the risks and benefits of estrogen and/or progestin replacement. The purpose of this review is to describe the risks and benefits of hormonal therapy, focusing on estradiol/norethindrone acetate combination therapy.Keywords: postmenopausal hormone therapy, norethindrone acetate, estradiolColleen L CaseyChristine A MurrayDove Medical PressarticleGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 3, Pp 9-16 (2008)
institution	DOAJ
collection	DOAJ
language	EN
topic	Geriatrics RC952-954.6
spellingShingle	Geriatrics RC952-954.6 Colleen L Casey Christine A Murray HT update: spotlight on estradiol/norethindrone acetate combination therapy
description	Colleen L Casey, Christine A MurrayUniversity of Vermont, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Burlington, VT, USAAbstract: The goal of postmenopausal hormone therapy is to alleviate the symptoms that are associated with the loss of estrogen. Many formulations of estrogen and progestin are available, depending on the needs and circumstances of each individual woman. For postmenopausal women, the choice of whether or not to begin therapy requires knowledge of the risks and benefits of estrogen and/or progestin replacement. The purpose of this review is to describe the risks and benefits of hormonal therapy, focusing on estradiol/norethindrone acetate combination therapy.Keywords: postmenopausal hormone therapy, norethindrone acetate, estradiol
format	article
author	Colleen L Casey Christine A Murray
author_facet	Colleen L Casey Christine A Murray
author_sort	Colleen L Casey
title	HT update: spotlight on estradiol/norethindrone acetate combination therapy
title_short	HT update: spotlight on estradiol/norethindrone acetate combination therapy
title_full	HT update: spotlight on estradiol/norethindrone acetate combination therapy
title_fullStr	HT update: spotlight on estradiol/norethindrone acetate combination therapy
title_full_unstemmed	HT update: spotlight on estradiol/norethindrone acetate combination therapy
title_sort	ht update: spotlight on estradiol/norethindrone acetate combination therapy
publisher	Dove Medical Press
publishDate	2008
url	https://doaj.org/article/f9a3f396214e4f22b59bcdaf6fcde6f3
work_keys_str_mv	AT colleenlcasey htupdatespotlightonestradiolnorethindroneacetatecombinationtherapy AT christineamurray htupdatespotlightonestradiolnorethindroneacetatecombinationtherapy
_version_	1718402018613133312

HT update: spotlight on estradiol/norethindrone acetate combination therapy

Ejemplares similares